Monday, October 30, 2023 10:17:08 AM
Recent DCPH News
- Form SC 14D9 - Solicitation, recommendation statements • Edgar (US Regulatory) • 05/13/2024 10:32:56 AM
- Form SC TO-T - Tender offer statement by Third Party • Edgar (US Regulatory) • 05/13/2024 10:31:05 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 11:27:06 AM
- Form SC TO-C - Written communication relating to an issuer or third party • Edgar (US Regulatory) • 05/06/2024 09:16:00 PM
- Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion • Business Wire • 04/29/2024 11:00:00 AM
- Deciphera Pharmaceuticals to Present at the Stifel 2024 Virtual Targeted Oncology Forum • Business Wire • 04/09/2024 11:00:00 AM
- Deciphera Pharmaceuticals to Participate in Upcoming Investor Conferences • Business Wire • 02/27/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:05:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:05:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:05:14 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:06:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:37 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/09/2024 09:30:32 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/07/2024 12:52:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/07/2024 12:11:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 12:10:02 PM
- Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2023 Financial Results • Business Wire • 02/06/2024 12:00:00 PM
- Deciphera Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call and Webcast on February 6, 2024 • Business Wire • 02/01/2024 09:50:00 PM
- Deciphera Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference • Business Wire • 02/01/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 09:15:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 09:15:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 09:15:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 09:15:19 PM
- Deciphera Pharmaceuticals Presents Long-Term Follow-Up Results from INTRIGUE Phase 3 Clinical Study in Second-Line GIST Patients at the 2024 American Society of Clinical Oncology Gastrointestinal Cancers Symposium • Business Wire • 01/18/2024 04:13:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 12:14:30 PM
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM